186 related articles for article (PubMed ID: 19262053)
1. [Case of primary malignant lymphoma of the liver treated by R-CHOP therapy].
Asagi A; Miyake Y; Ando M; Yasuhara H; Matsumoto K; Takahara M; Kawai D; Kaji E; Toyokawa T; Onishi T; Miyatani K; Nakatsu M
Nihon Shokakibyo Gakkai Zasshi; 2009 Mar; 106(3):389-96. PubMed ID: 19262053
[TBL] [Abstract][Full Text] [Related]
2. [A case of primary hepato-biliary malignant lymphoma effectively treated with R-CHOP chemotherapy].
Hiramoto K; Kuroki M; Shoji H; Matsumura Y; Miura A; Kikuchi Y; Hirakawa H; Kimura J; Matsuda M
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1345-8. PubMed ID: 20647724
[TBL] [Abstract][Full Text] [Related]
3. The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP.
Dawson MA; Mariani J; Taylor A; Koulouris G; Avery S
Ann Oncol; 2006 Jan; 17(1):176-7. PubMed ID: 16157624
[No Abstract] [Full Text] [Related]
4. [Case of malignant lymphoma arising from the posterior mediastinum, with pleural effusion].
Nagashima O; Takahashi K; Sato K; Suzuki T; Fukuchi Y; Isobe Y; Oshimi K
Nihon Kokyuki Gakkai Zasshi; 2004 Aug; 42(8):772-6. PubMed ID: 15455953
[TBL] [Abstract][Full Text] [Related]
5. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
[TBL] [Abstract][Full Text] [Related]
6. [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab].
Serrano-Navarro I; Rodríguez-López JF; Navas-Espejo R; Pérez-Jacoiste MA; Martínez-González MA; Grande C; Prieto S
Rev Esp Enferm Dig; 2008 Nov; 100(11):724-8. PubMed ID: 19159179
[TBL] [Abstract][Full Text] [Related]
7. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy.
Halaas JL; Moskowitz CH; Horwitz S; Portlock C; Noy A; Straus D; O'Connor OA; Yahalom J; Zelenetz AD
Leuk Lymphoma; 2005 Apr; 46(4):541-7. PubMed ID: 16019482
[TBL] [Abstract][Full Text] [Related]
8. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
[TBL] [Abstract][Full Text] [Related]
9. [The efficacy and adverse effects of rituximab with CHOP or THP-COP in old-old and extremely old patients with diffuse large B cell lymphoma].
Kikukawa M; Miyazaki K; Kiuchi A; Abe S; Fujii H; Kanaya K; Shin K; Iwamoto T
Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):236-40. PubMed ID: 16683659
[TBL] [Abstract][Full Text] [Related]
10. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
Ohkubo H; Yoshida T; Ohta K; Takaku T; Katagiri T; Paku J; Kasuga I; Minemura K; Gotoh A; Serizawa H; Mukai K; Ohyashiki K
Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
[TBL] [Abstract][Full Text] [Related]
12. [A case of primary hepatic lymphoma successfully treated by THP-COP therapy].
Takauchi K; Kono H; Ito T; Zaima K; Okumoto S
Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):65-8. PubMed ID: 12649851
[TBL] [Abstract][Full Text] [Related]
13. [A case of primary pulmonary malignant lymphoma associated with autoimmune hemolytic anemia].
Kubota Y
Nihon Kokyuki Gakkai Zasshi; 2006 Jun; 44(6):453-7. PubMed ID: 16841717
[TBL] [Abstract][Full Text] [Related]
14. FcgammaRIIB expression in diffuse large B-cell lymphomas does not alter the response to CHOP+rituximab (R-CHOP).
Camilleri-Broët S; Mounier N; Delmer A; Brière J; Casasnovas O; Cassard L; Gaulard P; Christian B; Coiffier B; Sautès-Fridman C
Leukemia; 2004 Dec; 18(12):2038-40. PubMed ID: 15470484
[No Abstract] [Full Text] [Related]
15. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
[TBL] [Abstract][Full Text] [Related]
16. [Case of malignant lymphoma of the prostate complicated with prostate adenocarcinoma].
Chin K; Fujimura M; Sekit N; Mikami K; Kamijima S; Suzuki H; Ichikawa T
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):698-702. PubMed ID: 19999135
[TBL] [Abstract][Full Text] [Related]
17. Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.
Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Yamamoto M; Nishizaki D; Takamatsu T; Iwasa Y
Gan To Kagaku Ryoho; 2007 May; 34(5):783-7. PubMed ID: 17496458
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation.
Nonami A; Takenaka K; Kamezaki K; Miyamoto T; Harada N; Nagafuji K; Teshima T; Harada M
Int J Hematol; 2007 Apr; 85(3):264-6. PubMed ID: 17483065
[TBL] [Abstract][Full Text] [Related]
19. Sustained remission after rituximab-containing chemotherapy for intravascular large B-cell lymphoma.
Shimada K; Kosugi H; Narimatsu H; Shimada S; Suzuki T; Ito M; Kinoshita T; Mori N; Naoe T
J Clin Exp Hematop; 2008 Apr; 48(1):25-8. PubMed ID: 18434690
[TBL] [Abstract][Full Text] [Related]
20. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].
Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K
Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
